Health Care Market News Sona Nanotech files patent application for photothermal light device Sona Nanotech (CSE:SONA) submits a patent application to the U.S. Patent and Trademark Office for its proprietary photothermal light device. Jocelyn Aspa2 mins18 March 2024 12:20 (EDT)
Health Care Market News Technology FendX and McMaster University partner on spray nanotechnology FendX Technologies (CSE:FNDX) reveals a partnership with McMaster University to advance the development of a spray nanotechnology. Jocelyn Aspa2 mins15 March 2024 13:36 (EDT)
Health Care Market News NDatalyze to acquire Mindbalanced NDatalyze (CSE:NDAT) has announced it has entered into an arms-length agreement to acquire a 100 per cent interest of Mindbalanced. Jocelyn Aspa2 mins14 March 2024 13:10 (EDT)
Health Care Market News Canadian biotech company reports positive autism treatment results Marvel Biosciences (TSXV:MRVL) reports promising interim results on its lead drug candidate, MB-204, as a new treatment for autism. Jonathon Brown2 mins12 March 2024 09:44 (EDT)
Health Care Market News Sponsored Why carbon-based imaging drug advancement is the future of life sciences The Canadian life sciences sector is one of the fastest growing industries in Canada as it seeks to make innovative products. Jocelyn Aspa3 mins12 March 2024 07:00 (EDT)
Health Care Market News FSD Pharma submits clinical trial application for Unbuzzd drink FSD Pharma (CSE:HUGE) has submitted a clinical trial application to assess its Unbuzzd beverage in a planned Phase 1b clinical trial. Jocelyn Aspa2 mins11 March 2024 13:42 (EDT)
Health Care Market News Novo Nordisk stock hits new high on next-gen weight-loss drug results Novo Nordisk (NYSE:NVO) stock jumped to a record high after it updated investors on positive results from a trial of a new weight loss… Jonathon Brown2 mins07 March 2024 09:12 (EDT)
Cannabis Health Care Market News Technology Buzz on the Bullboards: Who is shining through the market slump? The market story this week has been less impressive on both sides of the border than what we saw in the week where February… Jonathon Brown4 mins07 March 2024 05:01 (EDT)
Health Care Market News Bausch Health subsidiary reveals Phase 2 study of Relistor Bausch Health Companies has revealed that its subsidiary Salix Pharmaceuticals is initiating a Phase 2 study of its drug candidate Relistor Jocelyn Aspa2 mins06 March 2024 12:36 (EDT)
Health Care Market News Oncolytics Biotech to initiate new pancreatic cancer therapy study Oncolytics Biotech (TSX:ONC) initiated a new Phase 1/2 cohort to evaluate a novel treatment approach to pancreatic cancer. Jonathon Brown2 mins05 March 2024 09:52 (EDT)
Health Care Market News BioNxt completes study on its oral MS treatment BioNxt (CSE:BNXT) completed its comparative pharmacokinetic study for its oral dissolvable film to treat multiple sclerosis. Jonathon Brown2 mins04 March 2024 09:50 (EDT)
Health Care Market News MedX Health shares rise on skin cancer pilot project Shares of MedX Health (TSXV:MDX) received a boost Wednesday morning after the release of skin cancer pilot project results. Jocelyn Aspa2 mins28 February 2024 13:00 (EDT)
Health Care Market News Viking Therapeutics’ new weight-loss drug shows early potential Viking Therapeutics, a clinical-stage biopharmaceutical stock, is sharing positive top-line data from its phase-2 clinical trial of VK2735. Trevor Abes3 mins28 February 2024 10:52 (EDT)
Health Care Market News Technology Reliq Health Technologies expands mental health offering Reliq Health Technologies (TSXV:RHT) will now provide cognitive assessments as part of its mental health services to improve early detection. Trevor Abes2 mins28 February 2024 09:05 (EDT)
Health Care Market News Technology Contrarian play Datametrex AI sets sights on shareholder value Recent news flow from Datametrex AI (TSXV:DM) suggests the company is on the path to profitable growth and shareholder value generation. Trevor Abes2 mins27 February 2024 10:59 (EDT)
Health Care Market News Psychedelics Psychedelic stock clears hurdle to treating depression with LSD Psychedelic stock MindBio (CSE:MBIO) is revealing positive top-line data from its pioneering microdosing clinical trial to treat depression. Trevor Abes2 mins26 February 2024 09:03 (EDT)
Health Care Market News Psychedelics Clearmind Medicine to begin alcohol use disorder clinical trial Clearmind Medicine (CSE:CMND) has received approval to begin its phase I/IIa clinical trial for alcohol use disorder in Israel. Jocelyn Aspa2 mins23 February 2024 12:05 (EDT)
Health Care Market News Sponsored An investor’s gateway into the cancer immunotherapy market is with this Canadian biotechnology company The overarching cancer immunotherapy market continues growing at unprecedented rates, and BioVaxys Technology is ready to capitalize on it. Jocelyn Aspa4 mins23 February 2024 07:00 (EDT)
Health Care Market News Technology WELL Health streamlining business towards profitable growth WELL Health (TSX:WELL) has made an integration update to streamline its business operations and position itself for profitable growth. Jonathon Brown3 mins22 February 2024 10:02 (EDT)
Cannabis Health Care Industrial Market News Buzz on the Bullboards: Where volatility meets opportunity Some indices hit lows not seen in nearly a year after a concerning inflation report, only to bounce back the next day. Jonathon Brown4 mins15 February 2024 04:53 (EDT)